Pricing Log in Create free account
Sunday 11 October 2026 Export all VTR data to Excel Powerpack

Ventas, Inc.

VTR Real Estate Reit Healthcare Facilities

Ventas, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, up 18.5% from fiscal 2024. In the quarter to June 2026, revenue grew 21.7%, EPS fell 6.67%, free cash flow grew 13.6% and total debt fell 2.82%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for five; insiders bought in the last twelve months.

82.04 0.28 +0.34%
Market cap
$42.9B
P/E
149×
Fwd P/E
133×
Dividend yield
2.49%
F-score
7/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Ventas, Inc. (VTR) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
8-K Sep 10, 2026 5.02 Departure or appointment of directors or officers Officer departure
10-Q Jun 30, 2026 P1I2: 43 added · 7 removed · 44 modified
P2I1A: no changes 		Share dilution
8-K Jul 29, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 15, 2026 5.02 Departure or appointment of directors or officers; 8.01 Other events
8-K May 12, 2026 5.02 Departure or appointment of directors or officers; 5.07 Submission of matters to a vote of security holders; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K Apr 27, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 16, 2026 5.02 Departure or appointment of directors or officers
8-K Feb 9, 2026 8.01 Other events; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 14 added · 6 removed · 75 modified
1A: 50 added · 21 removed · 96 modified
7: 47 added · 50 removed · 83 modified
8-K Feb 5, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 7, 2026 1.01 Entry into a material definitive agreement; 2.03 Creation of a direct financial obligation; 9.01 Financial statements and exhibits
8-K Dec 2, 2025 8.01 Other events; 9.01 Financial statements and exhibits
8-K Nov 14, 2025 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Oct 29, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
10-K Dec 31, 2024

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.